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Abstract 
The fatty acid profile of vegetable oils (VOs), together with the poor ability of marine fish to 
convert polyunsaturated fatty acids (PUFA) to highly unsaturated fatty acids (HUFA), lead to 
important changes in the nutritional value of farmed fish fed VO, which include increased fat 
and 18:2n-6 and reduced n-3 HUFA. Echium oil (EO) has a good n-3/n-6 balance as well as an 
interesting profile with its high content of unusual fatty acids (SDA, 18:4n-3 and GLA, 18:3n-6) 
that are of increasing pharmacological interest. The effects of substituting 50 % of dietary fish 
oil (FO) by EO on gilthead seabream (Sparus aurata L.) enterocyte and hepatocyte lipid 
metabolism were studied. After 4 months of feeding, cell viability, total lipid contents and lipid 
class compositions were not affected by EO. The cells clearly reflected the fatty acid profile of 
the EO showing increased SDA, GLA and its elongation product 20:3n-6, and only minorly 
decreased n-3 HUFA compared to other VO. Metabolism of [1-14C]18:2n-6 and [1-14C]18:3n-3 
was also unaffected by EO in terms of total uptake, incorporation, β-oxidation and elongation-
desaturation activities.   
 
Keywords: 
 
1. Introduction 
 
Diets for the major carnivorous finfish species farmed in Europe have traditionally been based 
on fish meal and fish oil (FO) (Turchini et al., 2009). However, aquaculture will potentially 
utilize 80-100 % of the global fish oil supply by 2010 (Bell and Waagbo, 2008; Turchini et al., 
2009). As a consequence, the sustainable development of aquaculture requires dietary FO to be 
substituted with vegetable oils (VO) that are available, sustainable and cost effective (Sargent et 
al., 2002; Bell and Waagbo, 2008; Turchini et al., 2009).  
The poor ability of marine fish to convert linolenic (18:3n-3, LNA) and linoleic (18:2n-6, LA) 
acids to the highly unsaturated fatty acids (HUFA), 20:5n-3 (eicosapentaenoic, EPA), 22:6n-3 
(docosahexaenoic, DHA) and 20:4n-6 (arachidonic, ARA) compared to fresh water fish may be 
associated with the latter having higher concentrations of LNA and LA and limited EPA and, 
especially, DHA in their diet compared to the former (Sargent et al., 2002; Bell and Tocher, 
2009). Therefore, HUFA are essential fatty acids (EFA) for marine fish, and are important as 
structural components of cell membranes (Sargent et al., 2002; Marsh, 2008), eicosanoids 
precursors (Tocher, 2003; Bell et al., 2006; Villalta et al., 2007) and regulators of gene 
expression (Zheng et al., 2005; Miller et al., 2008; Leaver et al., 2008). The fatty acid profile of 
VO, together with this poor ability of marine fish to convert C18 polyunsaturated fatty acids 
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(PUFA) to HUFA, lead to important changes in the fatty acid composition of flesh of fish fed 
VOs, which include decreased n-3 HUFA and increased fat and LA contents (Sargent et al., 
2002; Menoyo et al., 2004; Bell et al., 2006; Benedito-Palos et al., 2007; Díaz-López et al., 
2009; Fountoulaki et al., 2009). Excessive consumption of VO and, particularly 18:2n-6, has 
been related to some detrimental effects on health of fish (McKenzie, 2001; Sargent et al., 2002; 
Montero et al., 2003,	  2008). For these reasons, replacement of dietary FO must be approached 
with caution, and is only possible in marine fish when HUFA are present in feeds at sufficient 
quantities to meet EFA requirements, and to maintain nutritional value for human consumption. 
In this sense, up to 50-70% substitution of FO by VO has been reported to maintain the correct 
growth and health of some marine fish species including seabream and seabass (Sargent et al., 
2002; Montero et al., 2003; Menoyo et al., 2004; Mourente et al., 2005; Benedito-Palos et al., 
2007; Díaz-López et al., 2009; Fountoulaki et al., 2009). However, research is now focused at 
identifying VOs or blends that avoid excessive deposition of fat and LA, provide a good n-3/n-6 
HUFA ratio, and maximize potential for conversion of C18 n-3PUFA to EPA and DHA. In this 
sense, there are several studies demonstrating that dietary VOs induce the conversion of LA to 
ARA, and LNA to EPA and DHA in both hepatocytes and enterocytes in salmonids, although 
total n-3 HUFA levels are still significantly decreased in flesh and liver (Bell et al., 2001, 2002; 
Tocher et al., 2002, 2004, 2006; Fonseca-Madrigal et al., 2006). However, HUFA synthesis is 
very low and generally not increased by dietary VOs in marine fish (Mourente et al., 2005; 
Almaida-Pagán et al., 2007).  
The Echium genus (Boraginaceae) seed oils are relatively rich in LNA and 18:4n-3 (stearidonic 
acid, SDA) as well as 18:3n-6 (γ-linolenic acid, GLA), and only contains moderate levels of LA 
compared to other VOs (Guil-Guerrero et al., 2000a,b). Thus, Echium oil (EO) has a good n-3/n-
6 PUFA balance as well as an interesting profile with its high content of unusual fatty acids 
(SDA and GLA) that are of increasing pharmacological interest based on their competitive and 
inhibitory effects in the production of proinflammatory eicosanoids derived from ARA (Tocher, 
2003; Villalta et al., 2007; Chilton et al., 2008; Whelan, 2009). The high levels of SDA, 
compared to LNA, may also facilitate its conversion into n-3 HUFA, since it does not require 
the first, rate-limiting, Δ6 desaturation step.  
Gilthead seabream, Sparus aurata L., is the most important marine fish species in 
Mediterranean and Canarian aquaculture, and several studies have shown that it can generally be 
grown well on diets with FO partially replaced by VO (Montero et al., 2003; Caballero et al., 
2003, 2004; Menoyo et al., 2004; Benedito-Palos et al., 2007; Díaz-López et al., 2009; 
Fountoulaki et al., 2009). However knowledge of seabream lipid metabolism is still incomplete 
compared to other fish species, such as salmonids, turbot, and seabass (Sargent et al., 2002; 
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Rodríguez et al., 2002; Mourente et al., 2005; Bell et al., 2001, 2002, 2006; Tocher et al., 2002, 
2004, 2006; Fonseca-Madrigal et al., 2006). Thus, neither HUFA synthesis, nor β-oxidation 
processes have been investigated in gilthead seabream.  
Hepatocytes and enterocytes play critical roles in lipid metabolism including uptake, oxidation, 
and conversion of fatty acids and the supply of HUFA to the other tissues. Much information of 
the biosynthetic pathways of HUFA synthesis and other aspects of fatty acid metabolism has 
been obtained by incubating isolated fish cells with radiolabeled fatty acids (Bell et al., 2001, 
2002, 2006; Rodríguez et al., 2002; Tocher et al., 2002, 2004, 2006; Mourente et al., 2005; 
Fonseca-Madrigal et al., 2006; Almaida-Pagán et al., 2007). Therefore, the aim of the present 
study was to evaluate the effects of 50% substitution of dietary FO by EO, in gilthead seabream 
lipid profile and fatty acid metabolism in isolated hepatocytes and enterocytes.  
 
2. Material and methods 
 
2.1. Fish, diets and sampling 
Gilthead seabream juveniles obtained from a local fish farm (CEDRA S.L.L.) were distributed 
into six 500L circular tanks (14 fish per tank) and reared under constantly flowing seawater, and 
natural photoperiod at 19-19.5 ºC, at Centro Oceanográfico de Canarias (I.E.O.) (Tenerife, 
Spain). After a 4-week acclimatization period, where fish were fed an extruded commercial diet 
(Aqualife 17, Biomar S.A., France), fish from three of the tanks were changed to a pelletized 
experimental diet containing 50 % FO and 50 % EO, manufactured by the Institute of 
Aquaculture at Stirling University (Scotland, U.K.). EO was produced by cold pressing of seeds 
from both Echium plantagineum and Echium vulgare (Goerlich Pharma, Spain). Proximate 
composition, lipid class and fatty acid profiles of the diets are shown in Table 1.  
The fish were fed ad libitum twice a day, from Monday to Friday. The fish, initial mass 265.05 
± 49.75 g, were sampled at the beginning of the experimental trial and then monthly, to obtain 
final growth and specific growth rates (SGR). Mortality was registered daily. After 4 months of 
feeding, 6 fish per dietary treatment were randomly collected, anesthetized with 1 mL of 
chlorobutanol in ethanol per litre seawater and killed by a blow to the head and liver and gut 
rapidly removed for cell isolation and subsequent metabolic assays. The entire experiment was 
conducted in accordance with Spanish law 223/1988 (B.O.E. 18th March) for protection of 
experimental animals, in agreement with European law 89/609/CE. 
 
2.2. Preparation of isolated enterocytes and hepatocytes.  
After 48 h of starvation, the foregut, including pyloric caeca, was rapidly removed from the 
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carcass, cleaned of adhering adipose tissue, and contents removed with cold (4 ºC) physiological 
saline solution III (Dópido et al., 2004). The intestine was then filled, immersed and incubated 
with a hyperosmolar solution. The process was repeated twice with the same solution containing 
0.2 mM  EDTA and 0.5 mM dithiothreitol (DTT) as disaggregants and then the luminal 
solution, mainly enterocytes loosened from the epithelia, was filtered. The resultant cell 
suspension was centrifuged and the pellet resuspended and incubated in a similar solution 
containing collagenase (0.5 mg/mL). Hepatocytes were prepared basically as described by 
Rodríguez et al. (2002).  Liver was cannulated through the hepatic portal vein or another 
suitable vessel to clear the liver of blood with a physiological solution. The liver was then finely 
chopped in a beaker with HBSS solution containing collagenase (1 mg/mL). Both gut and liver 
preparations were incubated with collagenase for 15 min at 25 ºC with shaking. The resultant 
cell suspensions were filtered through a 60-100 µm nylon mesh and centrifuged.  The cell pellet 
was washed with 20 mL of HBSS containing 1% w/v fatty acid-free bovine serum albumin 
(FAF-BSA) and re-centrifuged at 700 g for 15 min. The isolated cells were then suspended in 50 
mL of cold M199 medium (Rodríguez et al., 2002). Fifty to 100 µl samples of cell suspensions 
were collected and stored at -80 ºC for protein determination (Lowry et al., 1951). 
 
2.3. Enterocyte and hepatocyte viability. 
Cell viability was assessed by Trypan-blue dye exclusion and an oxygen consumption test prior 
to metabolic assays. In the Trypan blue dye exclusion method, 50µl cell suspensions were 
diluted with 200 µL 0.4% Trypan blue solution, stained for 5 min. at room temperature, and 
viable cells (dye excluded) counted using a Neubauer haemocytometer. Data were expressed as 
mean percentage of total viable cells. This measure was also taken after the incubation period in 
both, the control cells and cells with radiolabelled fatty acids.  
Oxygen consumption was measured on freshly isolated cells in an O2-saturated closed system 
using a Clark electrode connected to a computerized data acquisition system, and processed with 
RESPI software (Jeulin SAV, France). Approximately 120×106 cells in 3 mL M199 solution 
were added to the incubation chamber and maintained at 20 °C. After a 5 min stabilization 
period, O2 concentrations were linear with time and plotted on-line for 10-15 min. Experimental 
zero O2 concentration was obtained by adding sodium dithionite. The rate of O2 consumption 
(ROxygen) was calculated as the slope of the linear relationship in the plots [O2] versus time, and 
expressed in nmol O2/mg protein/hour (nmol O2·mg pp -1·h-1) (Dópido et al., 2004).  
 
2.4. Enterocyte and hepatocyte incubation with 14C-labelled fatty acids. 
 Six mL of each cell preparation were incubated as monolayers in plastic tissue culture flasks for 
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2 h at 20ºC with 70 µL (0.35 µCi) of either [1-14C]18:2n-6 or [1-14C]18:3n-3. The radiolabelled 
fatty acids were added to the medium as their potassium salts bound to FAF-BSA (Ghioni et al., 
1997). A third, control group of cells was also maintained under the same conditions, but 
without adding fatty acid to the incubation media, for subsequent lipid analysis. 
 
2.5. Enterocyte and hepatocyte lipid composition.  
After incubation, the 6 mL samples of control cells were centrifuged (700 x g, 15 min) and 
washed with Hanks balanced salt solution (HBSS). Chloroform/methanol (2:1, v/v) containing 
0.01% butylated hydroxytoluene (BHT) as antioxidant, was added to extract total lipids (TL) as 
described by Christie (1982). The organic solvent was evaporated under a stream of nitrogen 
and the lipid content determined gravimetrically. The TL extracts were stored in 
chloroform/methanol (2:1) with BHT at -20º C until analysis. The lipid class composition of TL 
from the control cells was determined by HPTLC using single-dimension double-development 
as previously described (Tocher and Harvie, 1988). The classes were quantified by charring 
followed by calibrated densitometry using a dual-wavelength flying spot scanner CS-9001PC 
(Shimadzu) (Olsen and Henderson, 1989) and identified according to known lipid class 
standards. Samples of TL were subjected to acid-catalyzed transmethylation in 1 mL toluene 
and 2 mL 1% sulfuric acid (v/v) in methanol, for 16 h at 50 ºC, and the resultant fatty acid 
methyl esters (FAME) purified by TLC (Christie, 1982). The FAME were separated and 
quantified using a Shimadzu GC-14A gas chromatograph equipped with a flame ionization 
detector (250 ºC) and a fused silica capillary column, Supelcowax TM 10 (30 m x 0.32 mm 
I.D.), as described in Díaz et al. (2009).  
 
2.6. Enterocyte and hepatocyte fatty acid metabolism 
Fatty acid metabolism was determined in the cells incubated with radiolabelled fatty acids. 
 
2.6.1. Beta-oxidation 
The assay of fatty acid oxidation in intact cells requires the determination of acid-soluble 
radioactivity as previously described (Frøyland et al., 2000). Briefly, after incubation, 1 mL of 
cells (1/6 of cell suspensions) was homogenized and centrifuged at 16000 g for 5 min, and 500 
µl supernatant placed into a microcentrifuge tube and 100 µL of 6% HBSS/FAF-BSA solution 
added. After mixing, protein was precipitated by the addition of 1 mL of ice-cold 4 M perchloric 
acid. After vortexing, tubes were centrifuged (16000 g, 10 min), 500 µL supernatant transferred 
to scintillation vials, and radioactivity determined in a RackBeta 1214 liquid scintillation β-
counter (LKB, Wallac, USA). Radioactive in dpm was transformed into pmol/mg protein/hour 
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(pmol·mg pp-1h-1), taking into account specific activity of each substrate and cell protein 
contents (Lowry et al., 1951). 
 
2.6.2. Incorporation into total lipids 
Lipid was extracted from the remaining 5 mL of cells as described in section 2.5 and 1/10 of the 
TL extracts taken for determining radioactive incorporation as described above. Data of total 
uptake of radiolabelled fatty acids was calculated as the sum of β-oxidation and incorporation 
into TL. 
 
2.6.3. Fatty acyl desaturation/elongation.  
The remainder of the TL extracts were subjected to acid-catalyzed transmethylation as described 
above (section 2.5), and FAME then applied as 3-cm streaks to TLC plates previously 
impregnated with 2 g silver nitrate in 20 mL acetonitrile and preactivated at 110 ºC for 30 min. 
The plates were fully developed in toluene/acetonitrile (95:5, v/v) to separate the labelled fatty 
acids according to chain length and degree of unsaturation (Wilson and Sargent, 1992). The 
developed TLC plates were placed in closed exposure cassettes (Exposure Cassete-K, BioRad, 
Madrid, Spain) in contact with a radioactive-sensitive phosphorus screen for 7 days (Imagen 
Screen-K, Biorad, Madrid, Spain). The screens were then scanned with an image acquisition 
system (Molecular Imager FX, BioRad), and the bands quantified first in percentage by the 
“Quantity One” image software and then transformed into pmol·mg pp-1h-1 taking into account 
incorporation into total lipids of each sample. Identification of labelled bands was confirmed by 
radiolabelled standards run on the same plates (Rodríguez et al., 2002). 
 
2.7. Chemical and reagents 
TLC (20x20 cm, Ø 0.25 mm) and HPTLC (10x10 cm, Ø 0.15 mm) plates, precoated with silica 
gel (without fluorescent indicator), were from Machery-Nagel (Düren, Germany). Fish oil 
standard (PUFA N-3) was supplied by SUPELCO (Supelco PARK, Bellefonte, PA, USA). All 
organic solvents used were of reagent grade and were from Panreac (Barcelona, Spain). 
OptiPhase “HiSafe” 2 scintillant liquid and radiolabelled fatty acids, [1-14C]18:2n-6 and [1-
14C]18:3n-3 were from PerkinElmer (USA). HBSS (Hanks Balanced Salt Solution), M199 with 
Hanks salts, collagenase type IV, FAF-BSA (bovine serum albumin essentially fatty acid free), 
butylated hydroxytoluene, potassium chloride and potassium bicarbonate were from Sigma 
(Spain). 
 
2.8. Statistical analysis 
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Results are presented as means ± S.D (n=42 for growth parameters and n=6 for the rest of data). 
The data were checked for normal distribution by the one-sample Kolmogorov-Smirnoff test as 
well as for homogeneity of the variance with the Levene test and, when necessary, arcsine 
transformation was applied. Effect of treatment was determined using the Student t-test (2 
variables) and P<0.05 was considered statistically different. Total lipid content of enterocytes 
and hepatocytes was analyzed by two-way ANOVA. The percentages of lipid classes and main 
fatty acids of enterocytes and hepatocytes were included as variables in a principal components 
analysis (PCA) model. Factor scores were subsequently analyzed by two-way ANOVA to study 
the combined effects of both: dietary treatments and type of cell, and their interactions. 
Statistical analysis was performed using SPSS (versions 15.0 and 17.0, SPSS Inc, Chicago, IL, 
USA). 
 
3. Results 
 
3.1. Diet composition 
Total lipid contents of the diets were equal and close to 21% (DWB) (Table 1). Total saturated 
fatty acids, particularly 16:0, were higher in the FO diet than in the EO diet. Monounsaturated 
fatty acids other than 16:1 were higher, and n-6 PUFA, 18:2n-6 and 18:3n-6, 3-fold higher in the 
EO diet compared to the FO diet. Total n-3 PUFA fatty acids were similar in the two diets, but 
EPA and DHA were 2- to 3-fold lower in the EO diet compared to the FO diet, whereas 18:4n-3 
and, especially, 18:3n-3, were much higher in the EO diet (Table 1).  
 
3.2. Growth and survival 
No significant differences were observed in fish final weight or length among dietary 
treatments, with values of 351.0 ± 60.0 g and 25.7 ± 1.5 cm for FO-fed fish and 343.3 ± 51.1 g 
and 25.5 ± 1.3 cm for EO-fed fish, and with an average specific growth rate (SGR) of 0.3 from 
the second month until the end of the experimental period, for both dietary regimes. Mortality 
over the experimental period was less than 1% for both treatments. 
 
3.3. Enterocyte and hepatocyte viability 
Viability of isolated enterocytes and hepatocytes was not significantly (P<0.05) different 
between the two dietary groups, with values of oxygen consumption of 42.6 ± 15.3 and 47.8 ± 
12.9 nmol/ mg pp for enterocytes from FO- and EO-fed fish, respecitively, and  28.6 ± 15.7 and 
37.9 ± 13.2 nmol/ mg pp for FO and EO-fed fish hepatocytes, respectively. Similarly, viability 
rate obtained by the Trypan-blue cell exclusion test was not significantly (P > 0.05) different 
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between the dietary groups with more than 91 % viability achieved even when radioactive 
substrates were added. 
 
3.4. Enterocyte and hepatocyte lipid composition. 
Two-way ANOVA of total lipid contents showed they were not affected by diet (p=0.745) but 
differed according to cell type (p=0.004) (Table 2). Similarly, lipid class profiles were generally 
not significantly affected by the dietary regime with the exception of cholesterol and steryl 
esters (SE) that were lower and higher, respectively, in hepatocytes from EO-fed fish (Table 2). 
There was a trend in EO enterocytes for TAG to be lower and structural lipids including 
phospholipids and cholesterol to be higher. The PCA (Fig 1) and two-way ANOVA of PCA 
highlights the significant differences between the lipid class profiles of the two cell types 
reflected in principal component 1 (PC1, p=0,000). PC1 was positively related with TAG and 
negatively with phosphatidylethanolamine (PE), phosphatidylcholine (PC), sphingomyelin (SM) 
and SE. Phospholipids (PC and PE) were more abundant in hepatocytes than enterocytes. 
After 4 months of feeding, enterocyte and hepatocyte fatty acid profiles clearly reflected those 
of diets (Table 3). Fish fed the EO diet showed significantly higher proportions of n-6 PUFA, 
including LA and GLA and also 20:3n-6, with the latter not being present in the diet. Similarly, 
LNA and SDA were also higher in cells from EO-fed fish, whereas n-3 HUFAs, trended to be 
lower. As a result, the n-3/n-6 ratio was significantly reduced in cells of fish fed the EO diet 
(Table 3). The PCA and two-way ANOVA for CP1 of fatty acids (p=0.000) confirmed these 
differences between dietary treatments (Fig. 2). The PC1 component was clearly related with the 
most abundant fatty acids in fish fed EO: LA, GLA, LNA, SDA and one of their elongation 
products (20:3n-6), so PC1 reflects the characteristic EO profile. However, the fatty acid profile 
was also affected, in principal component 2 (PC2), by the differences between enterocytes and 
hepatocytes profiles (p=0.009), which was negatively correlated with HUFA (ARA, 20:3n-3, 
20:4n-3, EPA, 22:5n-3 and DHA) and positively with oleic acid. The effect of EO was 
influenced by the cell type in PC1, shown by an interaction between dietary treatment and cell 
type (Interaction, p=0.031). Thus, enterocytes were more affected by EO showing higher levels 
of the characteristic EO-derived C18 PUFA compared to hepatocytes. Hepatocytes, in general, 
had more HUFA and less oleic acid than enterocytes. 
 
3.5. Enterocyte and hepatocyte metabolism of radiolabelled substrates 
3.5.1. Beta-oxidation, incorporation into total lipid and total absorption 
 Diet had no effect on β-oxidation of [1-14C]18:2n-6 or [1-14C]18:3n-3 in either enterocytes or 
hepatocytes (Table 4). Although β-oxidation expressed in absolute terms was similar in both 
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cellular types, when data were expressed relatively to total uptake, enterocyte β-oxidation was 
lower than that of hepatocytes (11-15 % in enterocytes vs. 27-37 % in hepatocytes). 
Incorporation of fatty acids into total lipids as well as total uptake (sum of β-oxidation and 
incorporation) were also similar for [1-14C]18:2n-6 and [1-14C]18:3n-3, independent of diet, but 
fatty acid uptake and incorporation were 2-3 times higher in enterocytes than hepatocytes (Table 
4).  
3.5.2. Fatty acyl desaturation/elongation. 
There were no marked differences between treatments in the production of elongated or 
desaturated products from the two fatty acid substrates (Table 4). Irrespective of experimental 
group, cell type, or fatty acid assayed, total radioactivity was almost recovered in a single band 
(97-99 %) which corresponded to the C18 PUFA added to the cells ([1-14C]18:2n-6 or [1-
14C]18:3n-3). Bands corresponding to elongation activity were clearer to define than those of 
desaturation. In this sense, some activity was recovered in 20:2n-6, 22:2n-6, 20:3n-3 and 22:3n-
3 whereas no clear bands for 18:3n-6 or 18:4n-3 or any of their elongation-desaturation products 
were found. 
 
4. Discussion  
 
As reported by other authors (Montero et al., 2003; Izquierdo et al., 2005) a 50% substitution of 
FO by VO is possible in gilthead seabream without negatively affecting the fish growth. 
In agreement with other similar studies performed with enterocytes and hepatocytes from fish 
fed VOs, cell viability was high (Rodríguez et al., 2002; Almaida-Pagán et al., 2007). Cell 
oxygen consumption was neither affected by diet showing values that were in the range 
previously reported for gilthead seabream enterocytes (Dópido et al., 2004). 
The inclusion of VOs in carnivorous fish diets is often associated with increased fat contents 
and lipid droplets in liver and enterocytes, usually when substitution is over 75% (Rodríguez et 
al., 2002; Caballero et al., 2003; Menoyo et al., 2004; Francis et al., 2007), or at lower levels of 
substitution when an unbalanced fatty acid profile is provided (Caballero et al., 2003, 2004; 
Menoyo et al., 2004). Nevertheless, when the substitution level is not too large (50-75 %) and 
the fatty acid profile of the VO is well balanced, fat deposition in enterocytes and liver is not 
reported (Caballero et al., 2004; Mourente et al., 2005; Francis et al., 2007). Moreover, in cod, 
Arctic charr and Atlantic salmon fed up to 100 % EO, TL in muscle and liver did not increase 
(Bell et al., 2006; Tocher et al., 2006; Miller et al., 2007), in agreement with our previous trial 
where muscle TL content of gilthead seabream fed EO was even decreased (Díaz-López et al., 
2009). Therefore, studies in marine fish should focus on the use of blends of VOs to obtain a 
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balanced fatty acid profile such as that present in EO to avoid excessive tissue fat deposition. In 
the same way, the lipid class profile of gilthead seabream enterocytes and hepatocytes was 
unaffected by EO as reported for other balanced VOs including EO in liver (Mourente et al., 
2005; Bell et al., 2006), enterocytes (Tocher et al., 2002) and muscle (Bell et al., 2006; Miller et 
al., 2007, 2008), of different fish species.  
Fatty acid profiles of enterocyte and hepatocyte reflected the dietary VO profile as widely 
observed for several fish species fed VO. In both cells types, the C18 fatty acids were 
significantly increased, but 22:5n-3 was only significantly reduced in hepatocytes. There was 
also a trend for DHA and EPA to decrease but not in a significant way. In many other trials, fish 
fed VOs displayed significant reductions in n-3HUFA together with increased C18 fatty acids in 
liver (Rodríguez et al., 2002; Menoyo et al., 2004; Mourente et al., 2005; Bell et al., 2006; 
Almaida-Pagán et al., 2007) and enterocytes (Caballero et al., 2003; Mourente et al., 2005; 
Almaida-Pagán et al., 2007) of different marine fish. Nevertheless, in seabass fed a balanced 
blend of VOs, enterocytes were capable at regulating fatty acid levels, with C18 fatty acids not 
increasing greatly, and EPA and DHA levels relatively maintained (Mourente et al., 2005). In 
our previous trial with seabream fed 50% EO, EPA, 22:5n-3 and DHA were reduced in muscle 
and liver after 4 months of feeding but, surprisingly, DHA was partly recovered in muscle after 
7 months of feeding (Díaz-López et al., 2009). In agreement with these findings white muscle of 
Atlantic salmon parr fed 100% EO, displayed an increment of DHA whereas EPA and 22:5n-3 
were maintained although growth rate was relatively low in this trial (Miller et al., 2007). The 
apparent compensation in the reduction of n-3 HUFA when using EO could be related to the 
moderated and balanced levels of C18 fatty acids of EO and some blends of VOs (Mourente et 
al., 2005). In this sense, the probability to esterify a n-3 HUFA instead of a C18 PUFA during 
phospholipid turnover may increase when proportions of dietary fatty acids are balanced. 
However, growth rate and duration of the feeding trial are also factors likely to affect final fatty 
acid compositions. 
The most abundant C18 fatty acids of VOs are LA, LNA and 18:1n-9, which were increased in 
enterocytes and hepatocytes of seabass, sharpsnout seabream and turbot fed VOs (Rodríguez et 
al., 2002; Mourente et al., 2005; Almaida-Pagán et al., 2007). Nevertheless, with EO other C18 
PUFA, including GLA (18:3n-6) and SDA (18:4n-3) increased in liver and muscle of freshwater 
and marine fish (Bell et al., 2006; Tocher et al., 2006; Miller et al., 2008; Díaz-López et al., 
2009), and also in enterocytes and hepatocytes in the present trial. The elongation products of 
these fatty acids, 20:3n-6 and 20:4n-3, are precursors of eicosanoids that have competitive and 
inhibitory effects on the production of proinflammatory eicosanoids derived from ARA in fish 
(Bell et al., 2006; Villalta et al., 2007) and in mammals (Chilton et al., 2008; Whelan, 2009). In 
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this respect, the fatty acid profile of seabream fed EO can be considered beneficial for human 
consumption. 
Another objective of the present study was to determine if the inclusion of EO improves the 
metabolism of the two main n-3 and n-6 HUFA precursors as has been described for some VOs 
in salmonids (Tocher et al., 2002, 2004; Fonseca-Madrigal et al., 2006) as studies with marine 
fish were lacking. The uptake of [1-14C]18:3n-3 and [1-14C]18:2n-6 by enterocytes and 
hepatocytes was unaffected by the EO diet, whereas in rainbow trout enterocytes fed linseed oil, 
increased uptake of [1-14C]18:3n-3, which was very abundant in this VO, was observed 
(Geurden et al., 2009). In rainbow trout fed rapeseed oil the uptake of [1-14C]18:3n-3 was 
maintained (Geurden et al., 2009) whereas it was decreased in hepatocytes  of salmon fed a VO 
blend (Stubhaug et al., 2005). This might be due to a higher uptake of 18:1n-9, more abundant 
than LNA in these diets. In the same way, the incorporation of both labelled fatty acids into TL 
was maintained with the EO in the present study and decreased in hepatocytes of salmon fed a 
VO blend with both fatty acids (Stubhaug et al., 2005).  
There was no effect of diet on β-oxidation as occurred in enterocytes and hepatocytes of other 
marine fish fed VOs (Mourente et al., 2005; Almaida-Pagán et al., 2007). We could expect that 
oxidation of the C18 PUFA, 18:2n-6 and 18:3n-3, abundant in VOs, would be increased in EO-
fed fish but this did not happen. However, studies measuring β-oxidation capacity in subcellular 
fractions, showed that long-chain monoenes were preferred over C18 PUFA as substrates in 
salmonids (Henderson 1996; Frøyland et al., 2000). Therefore, lower levels of long-chain 
monoenes and higher levels of C18 PUFA in VOs than in FO may result in increased β-oxidation 
of C18 PUFA in VO-fed gilthead seabream muscle (Menoyo et al., 2004), salmon enterocytes 
(Tocher et al., 2002), and sharpsnout seabream hepatocytes (Almaida-Pagán et al., 2007). 
However, in the present study, the EO diet had higher levels of long-chain monoenes than the 
FO diet so they were available for β-oxidation. Consistent with this, β-oxidation of the C18 
PUFA was similar in fish fed FO and VO when the VO blend had a similar level of long-chain 
monoenes to the FO diet (Mourente et al., 2005). In general, fish cells may use the most 
abundant fatty acids for β-oxidation but prefer long-chain monoenes to PUFA.   
Desaturation of the [1-14C] PUFA in gilthead seabream cells was very low as expected for a 
marine fish (Rodríguez et al., 2002; Mourente et al., 2005; Almaida-Pagán et al., 2007), and 
much lower than that reported for salmonids (Tocher et al., 2002, 2004, 2006). Increased HUFA 
synthesis has been described mainly in freshwater fish and salmonids fed VO diets at different 
levels of substitution (Bell et al., 2001, 2002; Tocher et al., 2002, 2004; Zheng et al., 2005; 
Stubhaug et al., 2005; Fonseca-Madrigal et al., 2006). Some of these trials also used EO, or even 
borage oil from the same plant family in salmonids (Tocher et al., 1997, 2006). These 
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increments have been related with increased expression of desaturases and elongase genes 
(Seiliez et al., 2003; Zheng et al., 2004, 2005; Miller et al., 2008). However, in marine fish, the 
effects of dietary VO appear to depend upon the species and does not increase HUFA synthesis 
unless the substitution is such that HUFA is under requirement levels which it is the case of 
Rodríguez et al. (2002) when feeding turbot 100% olive oil. Therefore, desaturation of [1-
14C]18:2n-6 and [1-14C]18:3n-3 was not increased in cod with 50 % VO substitution (~12% n-3 
HUFA) and in our trial with 50% of EO (11% n-3 HUFA), but it was in cod with 75 and 100% 
(7.9 and ~1.5 % n-3HUFA) (Francis et al., 2007) and with 100 % of EO (7.9 % n-3 HUFA) 
(Bell et al., 2006). In contrast, 100% VO substitution did not increase HUFA synthesis in the 
omnivorous marine fish, sharpsnout seabream (Almaida-Pagán et al., 2007). Moreover, studies 
with gilthead seabream larvae fed different degrees of substitution of FO by VOs did not show 
any indications of desaturation activity in tissue fatty acid profiles (Robin and Vincent, 2003; 
Robin and Peron, 2004), as in the present trial. However, molecular studies reported that the 
expression of the ∆6 desaturase gene was increased when seabream were fed 100% olive oil 
(Seileiz et al., 2003), similarly to the above mentioned results obtained in turbot fed 100% olive 
oil (Rodríguez et al., 2002).  
Despite the poor desaturation activity displayed for [1-14C]18:2n-6 and [1-14C]18:3n-3, 20:3n-6 
was significantly increased in the EO enterocytes and hepatocytes. This fatty acid was not 
supplied by the diet, which suggests elongation of the dietary precursor GLA, as happened in 
larvae seabream fed VO diet supplemented with Spirulina algae rich in GLA (Robin and Peron, 
2004). This elongation product is probably accumulated in seabream fed VO because Δ5 
desaturase activity required to produce 20:4n-6 is absent or very limited in these marine fish 
species (Tocher and Ghioni, 1999; Seiliez et al., 2003; Zheng et al., 2004). In contrast, there 
were no differences between the two treatments with respect to the presence of 20:4n-3 in cells. 
This may simply be a consequence of GLA, the 20:3n-6 precursor, being much higher in the EO 
diet (22 times fold) than in FO diet. Whereas, SDA, the 20:4n-3 precursor, was only two-fold 
higher in the EO diet compared to the FO diet, and also 20:4n-3 was much higher in the FO diet 
than 20:3n-6 and so differences in elongation were only able to be observed with 20:3n-6. The 
same situation concerning differences in dietary levels and the accumulation of elongation 
products, 20:3n-6 compared to 20:4n-3, were reported in liver of Arctic char fed EO and FO 
(Tocher et al., 2006), muscle and liver of cod fed EO and FO (Bell et al., 2006), and muscle and 
liver of gilthead seabream fed EO or FO in our previous trial (Díaz-López et al., 2009).  
In summary, enterocytes and hepatocytes TL contents and lipid class composition were not 
affected by 50 % substitution of FO by EO. The cells clearly reflected the fatty acid profile of 
the EO showing increments of healthy fatty acids including SDA, GLA and the elongation 
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product 20:3n-6. Metabolism of [1-14C]18:2n-6 and [1-14C]18:3n-3 was unaffected in terms of 
uptake, incorporation, β-oxidation and elongation-desaturation activities.   
 
Acknowledgements 
This study was supported by grants AGL 2003-06877 and CTM 2006-14279-C02-02 from the 
Spanish “Ministerio de Educación y Ciencia”. Dr. Covadonga Rodríguez was supported by a 
research position of the Ramón y Cajal Programme from Spanish Ministerio de Ciencia y 
Tecnología (MCYT) and FSE (RYC 2001-2824), and Mercedes Díaz López was supported by a 
grant from Caja Canarias. Drs. Covadonga Rodríguez and Antonio Lorenzo are members from 
the ITB of La Laguna University (Spain). 
 
References 
 
Almaida-Pagán, P.F., Hernández, M.D., García García, B., Madrid, J.A., De Costa, J., Mendiola, P., 
2007. Effects of total replacement of fish oil by vegetable oils on n-3 and n-6 polyunsaturated fatty 
acid desaturation and elongation in sharpsnout seabream (Diplodus puntazzo) hepatocytes and 
enterocytes. Aquaculture 272, 589-598.Bell, J.G., Waagbø, R., 2008. Safe and nutritious 
aquaculture produce: benefits and risks of alternative sustainable aquafeeds. In: Holmer, M., 
Black, K.D., Duarte, C.M., Marba, N., Karakassis, I., (Eds), Aquaculture in the Ecosystem, 
Springer Verlag BV, Berlin, pp. 185-225.  
Bell, M.V., Tocher, D.R., 2009. Biosynthesis of polyunsaturated fatty acids in aquatic ecosystems: general 
pathways and new directions. In: Kainz, M., Brett, M.T., Arts, M.T. (Eds), Lipids in Aquatic 
Ecosystems, Springer, New York, pp. 211-236. 
Bell, J.G., McEvoy, J., Tocher, D.R., McGhee, F., Campbell, P.J., Sargent, J.R., 2001. Replacement of 
fish oil with rapeseed oil in diets of Atlantic salmon (Salmo salar) affects tissue lipid compositions 
and hepatocyte fatty acid metabolism. J. Nutr. 131, 1535-1543. 
Bell, J.G., Henderson, R.J., Tocher, D.R., McGhee, F., Dick, J.R., Porter, A., Smullen, R., Sargent, J.R., 
2002. Substituting fish oil with crude palm oil in the diet of Atlantic salmon (Salmo salar) affects 
tissue fatty acid aompositions and hepatic fatty acid metabolism. J. Nutr.132, 222-230.  
Bell, J.G., Strachan, F., Good, J.E., Tocher, D.R., 2006. Effect of dietary echium oil on growth, fatty acid 
composition and metabolism, gill prostaglandin production and macrophage activity in Atlantic 
cod (Gadus morhua L.). Aquac. Res. 37, 606-617. 
Benedito-Palos, L., Saera-Villa, A., Calduch-Giner, J-A., Kaushik, S., Pérez-Sánchez, J., 2007. 
Combined replacement of fish meal and oil in practical diets for fast growing juveniles of gilthead 
sea bream (Sparus aurata L.): Networking of systemic and local components of GH/IGF axis. 
Aquaculture 267, 199-212. 
Caballero, M.J., Izquierdo, M.S., Kjorsvik, E., Montero, D., Socorro, J., Fernández, A.J., Rosenlund, G., 
2003. Morphological aspects of intestinal cells from gilthead seabream (Sparus aurata) fed diets 
containing different lipid sources. Aquaculture 225, 325-340. 
Caballero, M.J., Izquierdo, M.S., Kjorsvik, E., Fernández, A.J., Rosenlund, G., 2004. Histological 
alterations in the liver of sea bream, Sparus aurata L., caused by short or long-term feeding with 
vegetable oils. Recovery of normal morphology after feeding fish oil as the sole lipid source. J. 
Fish Diseases 27 (9), 531-541. 
15 
 
Chilton, F.H., Rudel, L.L., Parks, J.S., Arm, J.P., Seeds, M.C., 2008. Mechanisms by which botanical lipids 
affect inflammatory disorders. Am. J. Clin. Nutr. 87, 498S-503S.  
Christie, W.W., 1982. Lipid Analysis. In: Christie, W.W. (Ed.), Lipid Analysis, Pergamon Press, Oxford, pp 
17-23, 51-61. 
Díaz-López, M., Pérez M.J., Acosta, N.G., Tocher, D.R., Jerez, S., Lorenzo, A., Rodríguez, C., 2009. Effect 
of dietary substitution of fish oil by Echium oil on growth, plasma parameters and body lipid 
composition in gilthead seabeam (Sparus aurata). Aquac. Nutr. 15, 500-512.    
Dópido, R., Rodríguez, C., Gómez, T., Acosta, N.G., Díaz, M., 2004. Isolation and characterisation of 
enterocytes along the intestinal tract of the gilthead seabream (Sparus aurata). Comp. Biochem. 
Physiol. A 139, 21-31. 
Fonseca-Madrigal, J., Bell, J.G., Tocher, D.R., 2006. Nutritional and environmental regulation of the 
synthesis of highly unsaturated fatty acids and of fatty-acid oxidation in Atlantic salmon (Salmo 
salar L.) enterocytes and hepatocytes. Fish Physiol. Biochem. 32, 317-328. 
Fountoulaki, E., Vasilaki, A., Hurtado, R., Grigorakis, K., Karacostas, I., Nengas, I., Rigos, G., 
Kotzamanis, Y., Venou, B., Alexis, M.N., 2009. Fish oil substitution by vegetable oils in 
commercial diets for gilthead sea bream (Sparus aurata L.); effects on growth performance, flesh 
quality and fillet fatty acid profile. Recovery of fatty acid profiles by a fish oil finishing diet under 
fluctuating water temperatures. Aquaculture 289, 317-326. 
Francis, D.S., Turchini, G.M., Jones, P.L., De Silva, S.S., 2007. Effects of fish oil substitution with a mix 
blend vegetable oil on nutrient digestibility in Murray cod, Maccullochella peellii peelii. 
Aquaculture 269, 447-455. 
Frøyland, L., Lie, Ø., Berge, R.K., 2000. Mitochondrial and peroxisomal beta-oxidation capacities in 
various tissues from Atlantic salmon Salmo salar. Aquacult. Nutr. 6, 85-89. 
Geurden, I., Jutfelt, F., Olsen, R.E., Sundell, K.S., 2009. A vegetable oil feeding history affects 
digestibility and intestinal fatty acid uptake in juvenile rainbow trout oncorhynchus mykiss. Comp. 
Biochem. Physiol. A 152, 552-559. 
Ghioni, C., Tocher, D.R., Sargent, J.R., 1997. The effect of culture on morphology, lipid and fatty acid 
composition, and polyunsaturated fatty acid metabolism of rainbow trout (Oncorhynchus mykiss) skin 
cells. Fish Physiol. Biochem. 16, 499-513. 
Guil Guerrero, J.L., Rebolloso-Fuentes, M.M., Campra-Madrid, P., García-Maroto, F., 2000a. Occurrence 
and characterization of oils rich in gamma-linolenic acid (I): Echium from Macaronesia. 
Phytochemistry 53, 451-456.  
Guil-Guerrero, J.L., García-Maroto, F., Campra-Madrid, P., Gómez-Mercado, F., 2000b. "Occurrence and 
characterization of oils rich in gamma-linolenic acid (II): fatty acids and squalene from Macaronesian 
Echium leaves". Phytochemistry  56, 525-529.  
Henderson, R.J., 1996. Fatty acid metabolism in freshwater fish with particular reference to polyunsaturated 
fatty acids. Arch. Anim. Nutr. 49, 5-22. 
Izquierdo, M.S., Montero, D., Robaina, L., Caballero, M.J., Rosenlund, G., Ginés R., 2005. Alterations 
in fillet fatty acid profile and flesh quality in gilthead seabream (Sparus aurata) fed vegetable oils 
for a long term period. Recovery of fatty acid profiles by fish oil feeding. Aquaculture 250, 431-
444. 
Leaver, M.J., Villeneuve, L.A.N., Obach, A., Jensen, L., Bron, J.E., Tocher, D.R., Taggart, J.B., 2008. 
Functional genomics reveals increases in cholesterol biosynthetic genes and highly unsaturated 
fatty acid biosynthesis after dietary substitution of fish oil with vegetable oils in Atlantic salmon 
(Salmo salar). BMC Genomics 9, 299. 
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the folin 
phenol reagent. J. Biol. Chem. 193, 265-275. 
16 
 
Marsh, D., 2008. Protein modulation of lipids, and vice-versa, in membranes. Biochim. Biophys. Acta 
1778, 1545-1575. 
McKenzie, D. J., 2001. Effects of dietary fatty acids on the respiratory and cardiovascular physiology of 
fish. Comp. Biochem. Physiol. A 128, 605-619. 
Menoyo, D., Izquierdo, M.S., Robaina, L., Gines, R., López-Bote, C.J., Bautista, J.M., 2004. Adaptation 
of lipid metabolism, tissue composition and flesh quality in gilthead sea bream (Sparus aurata) to 
the replacement of dietary fish oil by linseed and soyabean oils. Br. J. Nutr. 92, 41-52. 
Miller, M.R., Nichols, P.D., Carter, C.G., 2007. Replacement of dietary fish oil for Atlantic salmon parr 
(Salmo salar L.) with a stearidonic acid containing oil has no effect on omega-3 long-chain 
polyunsaturated fatty acid concentrations. Comp. Biochem. Physiol. B 146, 197-206. 
Miller, M.R., Bridle, A.R., Nichols, P.D., Carter, C.G., 2008. Increased elongase and desaturase gene 
expression with stearidonic acid enriched diet does not enhance long-chain (n-3) content of 
seawater Atlantic salmon (Salmo salar L.). J. Nutr. 138, 2179-2185.  
Montero, D., Kalinowski, T., Obach, A., Robaina, L., Tort, L., Caballero, M.J., Izquierdo, M.S., 2003. 
Vegetable lipid sources for gilthead seabream (Sparus aurata): effects on fish health. Aquaculture 
225, 353-370. 
Montero, D., Grasso, B., Izquierdo, M., Real, F., Tort, L., Caballero, M.J., Acosta, F., 2008. Total 
substitution of fish oil by vegetable oils in gilthead sea bream (Sparus aurata) diets: effects on 
hepatic Mx expression and some immune parameters. Fish Shellfish Immunol. 24, 147-155.  
Mourente, G., Dick, J.R., Bell, J.G., Tocher, D.R., 2005. Effect of partial substitution of dietary fish oil by 
vegetable oils on desaturation and β-oxidation of [1-14C] 18:3n-3 (LNA) and [1-14C] 20:5n-3 (EPA) in 
hepatocytes and enterocytes of European seabass (Dicentrarchus labrax L.). Aquaculture 248, 173-
186. 
Olsen, R.E., Henderson, R.J., 1989. The rapid analysis of neutral and polar marine lipids using double-
development HPTLC and scanning densitometry. J. Exp. Mar. Biol. Ecol. 129, 189-197. 
Robin, J.H., Vicent, B., 2003. Microparticulate diets as first food for gilthead sea bream larva (Sparus 
aurata): Study of fatty acid incorporation. Aquaculture 225, 463-474. 
Robin, J.H., Person, A., 2004. Consuption v.s. deposition of essential fatty acids in gilthead sea bream 
(Sparus aurata) larvae fed semi-purified diets. Aquaculture 238, 283-294. 
Rodríguez, C., Pérez, J.A., Henderson, J.R., 2002. The esterification and modification of n-3 and n-6 
polyunsaturated fatty acids by hepatocytes and liver microsomes of turbot (Scophthalmus maximus). 
Comp. Biochem. Physiol. B 132 (3), 559-570. 
Sargent, J.R., Tocher, D.R., Bell, J.G., 2002. The lipids. In: Halver, J.E., Hardy, R.W. (Eds), Fish Nutrition, 
Third Edition, Academic Press, New York, pp. 181-257. 
Seileiz, I., Paserat, S., Corraze, G., Kaushik, S., Bergot, P., 2003. Cloning and nutrional regulation of a 
∆6-desaturase-like enzyme in the marine teleost gilthead seabream (Sparus aurata L.). Comp. 
Biochem. Physiol. B 135, 449-460. 
Stubhaug, I., Tocher, D.R., Bell, J.G., Dick, J.R., Torstensen, B.E., 2005. Fatty acid metabolism in Atlantic 
salmon (Salmo salar L.) hepatocytes and influence of dietary vegetable oil. Biochim. Biophys. Acta 
1734, 277-288. 
Tocher, D.R., 2003. Metabolism and functions of lipids and fatty acids in teleost fish. Rev. Fish. Sci. 11, 
107-184. 
Tocher, D.R., Harvie, D.G., 1988. Fatty acid compositions of the major phosphoglycerides from fish neural 
tissues: (n-3) and (n-6) polyunsaturated fatty acids in rainbow trout (Salmo gairdneri L.) and cod 
(Gadus morhua) brains and retinas. Fish Physiol. Biochem. 5, 229-239. 
Tocher, D. R., Ghioni, C., 1999. Fatty acid metabolism in marine fish: low activity of fatty acyl Δ5 
dasaturation in gilthead seabream (Sparus aurata) cells. Lipids 34, 433-440. 
17 
 
Tocher, D.R., Bell, J.G., Dick, J.R., Sargent, J.R., 1997. Fatty acyl desaturation in isolated hepatocytes from 
Atlantic salmon (Salmo salar): Stimulation by dietary borage oil containing γ-linolenic acid. Lipids 32 
(12), 1237-1247. 
Tocher, D. R., Fonseca-Madrigal, J., Bell, J.G., Dick, J.R., Henderson, R.J., Sargent, J.R., 2002. Effects of 
diets containing linseed oil on fatty acid desaturation and oxidation in hepatocytes and intestinal 
enterocytes in Atlantic salmon (Salmo salar). Fish Physiol. Biochem. 26, 157-170. 
Tocher, D.R., Fonseca-Madrigal, J., Dick, J.R., Wing Keong, N.G., Bell, J.G., Campbell, P.J., 2004. Effects 
of water temperature and diets containing palm oil on fatty acid desaturation and oxidation in 
hepatocytes and intestinal enterocytes of rainbow trout (Oncorhynchus mykiss). Comp. Biochem. 
Physiol. B 137, 49-63. 
Tocher, D.R., Dick, J.R., MacGlaughlin, P., Bell., J.G., 2006. Effect of diet enriched in ∆6 desaturated fatty 
acids (18:3n-6 and 18:4n-3), on growth, fatty acid composition and highly unsaturated fatty acid 
synthesis in two populations of Arctic charr (Salvelinus alpinus L.). Comp. Biochem. Physiol. B 144, 
245-253. 
Turchini, G.M., Torstensen, B.E., Ng, W.K., 2009. Fish oil replacement in finfish nutrition. Rev. Aquacult. 
1, 10-57. 
Villalta, M., Estévez, A., Bransden, M.P., Bell, J.G., 2007. Arachidonic acid, arachidonic/eicosapentaenoic 
acid ratio, stearidonic acid and eicosanoids are involved in dietary-induced albinism in Senegal sole 
(Solea senagalensis). Aquacult. Nutr. 13, 1-9. 
Whelan, J., 2009. Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potencial 
health benefits. J. Nutr. 139, 1-6. 
Wilson, R., Sargent, J.R., 1992. High resolution separation of polyunsaturated fatty acids by argentation thin-
layer chromatography. J. Chromatogr. 623, 403-407. 
Zheng, X., Seiliez, I., Hastings, N., Tocher, D. R., Panserat, S. C., Dickson, A., Bergot, P., Teale, A.J. 2004. 
Characterization and comparison of fatty acyl D6 desaturase cDNAs from freshwater and marine 
teleost fish species. Comp. Biochem. Physiol. B 139, 269-279. 
Zheng, X., Torstensen, B., Tocher, D.R., Dick, J.R., Henderson, R.J., Bell, J.G., 2005. Environmental and 
dietary influences on highly unsaturated fatty acid biosynthesis and expression of fatty acyl desaturase 
and elongase genes in liver of Atlantic salmon (Salmo salar). Biochim. Biophys. Acta 1734, 13-24. 
 
Legends 
 
Fig 1. a) Factor loadings plot for the lipid classes data. b) Plot of factor scores of the lipid classes for 
each fish categorized by dietary treatment (□: fish oil. ■: Echium oil); c) Plot of factor scores of the lipid 
classes for each fish categorized by type of cell (∆: enterocytes. ▲: hepatocytes). SM: Sphingomyelin. 
PC: Phosphatidylcholine. PS: Phosphatidylserine. PI: Phosphatidylinositol. PG: Phosphatidylglycerol 
(may also include phosphatidic acid and cardiolipin). PE: Phosphatidylethanolamine. DAG: 
Diacylglycerol. CHO: Cholesterol. FFA: Free fatty acids. TAG: Triacylglycerols. SE: Sterol esters. UK: 
Unknown. 
 
Fig 2. a) Factor loadings plot for the fatty acids data. b) Plot of factor scores of the fatty acids for each 
fish categorized by dietary treatment (□: fish oil. ■: Echium oil); c) Plot of factor scores of the fatty acids 
for each fish categorized by type of cell (∆: enterocytes. ▲: hepatocytes). UK: Unknown. 
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Table 1. Proximate composition (%DWB) and fatty acid composition (weight %) of dietary 
treatments.  
 FO diet EO diet 
       
Moisture  9.0 ± 1.1 8.9 ± 0.3 
Ash 7.3 ± 0.2 8.7 ± 0.4 
Crude fibre  3.0 ± 0.1 3.1 ± 0.1 
Protein 41.6 ± 0.6 43.4 ± 0.9 
Fat 20.7 ± 1.6 20.7 ± 0.8 
Neutral lipid 19.1 ± 0.1 18.8 ± 0.1 
Polar lipid  1.6 ± 0.1 1.9 ± 0.1 
16:0 18.7 ± 0.4 10.8 ±   - 
18:0 3.6 ± 0.2 2.2 ±   - 
Total saturates 30.5 ± 0.3 17.0 ±   - 
16:1 1 6.7 ±   - 3.5 ±   - 
18:1 n-9 9.8 ± 0.3 12.3 ±   - 
20:1 2 2.1 ±   - 6.5 ±   - 
22:1 2  1.8 ± 0.2 7.3 ±   - 
Total monoenes 25.9 ± 0.1 32.9 ± 0.2 
18:2 n-6 4.4 ± 0.1 13.4 ±   - 
18:3 n-6 0.2 ±   - 4.7 ±   - 
20:2 n-6 0.2 ±   - 0.2 ±   - 
20:3 n-6 0.1 ± 0.1 0.0 ±   - 
20:4 n-6 0.8 ±   - 0.1 ± 0.2 
Total n-6 PUFA 6.1 ± 0.2 18.5 ± 0.3 
18:3 n-3 1.4 ± 0.1 14.0 ±   - 
18:4 n-3 2.8 ± 0.1 5.4 ±   - 
20:3 n-3 0.2 ±   - 0.3 ± 0.1 
20:4 n-3 0.7 ±   - 0.1 ± 0.2 
20:5 n-3 12.3 ± 0.5 4.3 ±   - 
22:5 n-3 1.4 ± 0.1 0.4 ±   - 
22:6 n-3 13.1 ± 0.2 5.6 ±   - 
Total n-3 PUFA 32.9 ± 0.7 30.6 ± 0.3 
Total n-3 HUFA 28.2 ± 0.7 11.0 ± 0.3 
UK 1.5 ± 0.3 0.5 ± 0.1 
n-3/n-6 5.4 ± 0.3 1.7 ±   - 
18:1/n-3 HUFA 0.4 ±   - 1.3 ±   - 
DHA/EPA 1.1 ±   - 1.3 ±   - 
ARA/EPA 0.1 ±   - 0.0 ±   - 
Results represent means ± SD (n=3), SD < 0.1 is represented as “-”. Totals include some minor components not 
shown. DWB: Dry weight basis. pp: protein. FO: Fish oil. EO: Echium oil. UK: Unknown. 1 May contain n-9 and 
n-7 isomers. 2 May contain n-11 and n-9 isomers.  
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Table 2. Total lipid contents (µg lipid·mg pp-1) and lipid class composition (% of total lipid) of 
enterocytes and hepatocytes of gilthead seabream fed fish oil or Echium oil. 
 Enterocytes  Hepatocytes 
 FO diet EO  diet   FO diet EO  diet  
TL  100.8 ± 38.4 106.8 ± 19.0  156.8 ± 60.1 148.0 ± 35.9 
Sphingomyelin 0.6 ± 0.5 0.9 ± 0.2  1.2 ± 0.4 0.8 ± 0.2 
Phosphatidylcholine 10.9 ± 3.5 14.1 ± 3.3  14.0 ± 2.5 13.2 ± 0.8 
Phosphatidylserine 1.1 ± 0.5 1.9 ± 0.6  0.8 ± 0.5 0.8 ± 0.3 
Phosphatidylinositol 2.2 ± 1.0 3.2 ± 0.7  1.7 ± 1.0 1.5 ± 0.9 
Phosphatidylglycerol1 2.3 ± 1.0 2.2 ± 0.9  3.6 ± 0.9 3.1 ± 0.9 
Phosphatidylethanolamine 5.1 ± 1.3 7.3 ± 2.6  11.4 ± 3.1 13.5 ± 3.0 
Diacylglycerol  0.9 ± 1.1 0.2 ± 0.5  0.4 ± 0.7 0.4 ± 0.3 
Cholesterol 17.0 ± 4.8 20.2 ± 2.4  15.6 ± 1.5 13.4 ± 2.0   * 
Free fatty acids 5.6 ± 4.0 4.9 ± 5.1  7.0 ± 2.7 4.5 ± 1.9 
Triacylglycerols 47.1 ± 10.6 37.6 ± 6.0  35.7 ± 5.6 37.5 ± 6.7 
Sterol esters 3.8 ± 1.3 4.8 ± 1.4  5.7 ± 1.7 9.1 ± 2.6   * 
UK 3.2 ± 2.0 2.7 ± 2.0  2.7 ± 1.6 2.0 ± 1.7 
Total polar lipids 22.3 ± 6.6 29.5 ± 7.0 
 
32.8 ± 3.7 33.1 ± 3.2 
Total neutral lipids 74.5 ± 5.9 67.8 ± 8.8  64.5 ± 4.6 64.9 ± 4.0 
Results represent means ± SD (n=6). Pairs of values within a given cell type which are significantly different 
(P<0.05) are shown (*). pp: protein. FO: Fish oil. EO: Echium oil. TL: Total lipid. 1 May also include phosphatidic 
acid and cardiolipin. UK: Unknown. 
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Table 3. Total fatty acid contents (µg·mg-1pp-1) and fatty acid composition (weight %) of isolated 
enterocytes and hepatocytes of gilthead seabream fed fish oil or Echium oil.  
 Enterocytes   Hepatocytes 
 FO diet EO  diet    FO diet EO  diet  
Total FA 47.1 ± 2.7 51.2 ± 5.8  60.5 ± 14.1 67.5 ± 12.2 
14:0 3.7 ± 1.1 2.6 ± 0.7  3.6 ± 0.6 2.8 ± 0.9 
16:0 23.0 ± 3.9 20.1 ± 1.9  21.8 ± 3.8 20.0 ± 2.9 
18:0 7.7 ± 2.3 7.6 ± 0.5  6.2 ± 0.9 7.3 ± 1.8 
Total saturates 36.7 ± 6.4 32.4 ± 3.0  33.3 ± 5.3 31.8 ± 5.0 
16:1 1 5.3 ± 1.0 4.8 ± 0.9  6.8 ± 5.9 5.0 ± 1.3 
18:1 n-9 11.8 ± 1.7 13.8 ± 3.3  11.7 ± 2.0 12.2 ± 1.1 
20:1 2 3.6 ± 1.2 3.0 ± 1.0  2.4 ± 0.3 2.4 ± 0.3 
22:1 2  3.1 ± 1.9 1.6 ± 0.6  2.2 ± 0.5 1.8 ± 0.6 
24:1 n-9 0.8 ± 0.2 1.1 ± 0.6  1.6 ± 0.3 1.8 ± 1.0 
Total monoenes 28.4 ± 4.1 27.5 ± 5.4  27.6 ± 3.4 26.9 ± 3.9 
18:2 n-6 4.4 ± 0.7 8.8 ± 1.1 * 3.8 ± 0.3 7.5 ± 1.5   * 
18:3 n-6 0.1 ± 0.1 1.5 ± 0.3 * 0.1 ± 0.1 1.1 ± 0.4   * 
20:2 n-6 0.3 ± 0.1 0.3 ± 0.1  0.3 ±   - 0.3 ± 0.2 
20:3 n-6 0.1 ± 0.2 0.8 ± 0.4 * 0.1 ± 0.1 0.8 ± 0.3   * 
20:4 n-6 1.2 ± 0.2 1.0 ± 0.4  1.2 ± 0.3 1.2 ± 0.6 
Total n-6 PUFA 6.4 ± 1.0 12.4 ± 1.8 * 5.9 ± 0.6 11.3 ± 2.5   * 
18:3 n-3 0.8 ± 0.2 4.5 ± 0.8 * 0.8 ± 0.1 3.7 ± 1.5   * 
18:4 n-3 0.7 ± 0.4 1.4 ± 0.3 * 0.8 ± 0.1 1.3 ± 0.4   * 
20:3 n-3 0.0 ±   - 0.1 ± 0.1  0.1 ± 0.1 0.2 ± 0.2 
20:4 n-3 0.6 ± 0.1 0.6 ± 0.2  0.8 ± 0.1 0.8 ± 0.2 
20:5 n-3 5.9 ± 1.9 4.4 ± 1.8  5.4 ± 1.4 3.8 ± 1.1 
22:5 n-3 1.5 ± 0.6 0.8 ± 0.5  2.5 ± 0.5 1.6 ± 0.3   * 
22:6 n-3 15.7 ± 2.8 13.3 ± 6.7  19.1 ± 5.9 15.3 ± 4.0 
Total n-3 PUFA 29.6 ± 4.6 27.6 ± 5.9  36.4 ± 6.2 32.2 ± 3.2 
Total n-3 HUFA 23.6 ± 4.4 19.3 ± 8.5  28.0 ± 7.8 21.7 ± 5.3 
UK 1.5 ± 0.4 1.2 ± 0.9  1.5 ± 0.5 1.5 ± 0.9 
n-3/n-6 4.7 ± 0.4 2.3 ± 0.6 * 6.2 ± 0.8 2.9 ± 0.6   * 
18:1/n-3 HUFA 0.5 ± 0.2 0.9 ± 0.6  0.5 ± 0.2 0.6 ± 0.2 
DHA/EPA 2.9 ± 0.9 3.0 ± 1.1   3.5 ± 0.3 4.2 ± 0.6   * 
ARA/EPA 0.2 ±   - 0.2 ±   -  0.2 ±   - 0.3 ± 0.1 
Results represent means ± SD (n=6) , SD<0.1 is represented as “-”. Totals include some minor components not 
shown. Pairs of values within a given cell type which are significantly different (P<0.05) are shown (*). pp: protein. 
FO: Fish oil. EO: Echium oil. FA: fatty acids. 1 May contain n-9 and n-7 isomers. 2 May contain n-11 and n-9 
isomers. UK: Unknown. 
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Table 4. Metabolic activities: uptake, β-oxidation, incorporation and elongation-desaturation (pmol·mg 
pp-1·h-1), of enterocytes and hepatocytes of gilthead seabream fed fish oil or Echium oil, incubated with of [1-
14C]18:2n-6 and [1-14C]18:3n-3.  
 Enterocyte Hepatocyte 
  FO diet EO  diet  FO diet   EO  diet    
18:2n-6                  
Uptake 161.1 ± 46.1 133.4 ± 42.3 57.1 ± 21.0 †  53.5 ± 10.4   † 
β-oxidation 20.2 ± 15.4 18.2 ± 5.7 15.5 ± 10.6   19.9 ± 2.4  
Incorporation 140.9 ± 41.1 115.3 ± 44.3 41.7 ± 12.5 †  33.6 ± 10.7   † 
18:2n-6 138.2 ± 32.7 113.2 ± 38.8 41.0 ± 12.2 †  33.2 ± 10.4   † 
20:2n-6 1.0 ± 0.8 0.7 ± 0.6 0.2 ± 0.1   0.0 ± 0.0 *† 
22:2n-6 0.8 ± 0.5 0.7 ± 0.4 0.2 ± 0.1 †  0.1 ± 0.2   † 
tri-tetraenes 0.3 ± 0.2 0.4 ± 0.3 0.3 ± 0.2   0.2 ± 0.2  
pent-hexaenes 0.6 ± 0.4 0.4 ± 0.3 0.0 ± 0.1 †  0.1 ± 0.1   † 
elongation 1.8 ± 1.3 1.3 ± 0.8 0.4 ± 0.2 †  0.1 ± 0.3 *† 
desaturation 0.9 ± 0.5 0.8 ± 0.6 0.3 ± 0.2 †  0.2 ± 0.2     
elongation/desaturation 2.8 ± 1.4 2.1 ± 1.4 0.7 ± 0.4 †  0.4 ± 0.4   † 
18:3n-3                             
Uptake 136.9 ± 19.2 134.3 ± 42.0 63.3 ± 13.7 †  61.0 ± 16.5   † 
β-oxidation 20.4 ± 15.1 16.0 ± 6.3 19.6 ± 13.3   20.4 ± 3.3  
Incorporation 116.5 ± 31.8 118.3 ± 43.2 43.7 ± 18.2 †  40.6 ± 16.7   † 
18:3n-3 115.6 ± 57.1 116.6 ± 41.4 43.5 ± 18.0 †  40.0 ± 17.7   † 
20:3n-3 0.6 ± 0.3 1.0 ± 1.4 0.1 ± 0.1 †  0.3 ± 0.2 * 
22:3n-3 0.5 ± 0.4 0.5 ± 0.4 0.2 ± 0.2 †  0.2 ± 0.1  
tetraenes 0.0 ± 0.1 0.0 ± 0.0 0.0 ± 0.1   0.0 ± 0.0  
pent-hexaenes 0.6 ± 0.5 0.2 ± 0.4 0.0 ± 0.0 †  0.1 ± 0.1  
elongation 1.1 ± 0.7 1.5 ± 1.6 0.2 ± 0.3 †  0.5 ± 0.2  
desaturation 0.6 ± 0.6 0.2 ± 0.4 0.0 ± 0.1 †  0.1 ± 0.1  
elongation/desaturation 1.7 ± 1.2 1.7 ± 2.0 0.3 ± 0.3 †  0.6 ± 0.3  
Results represent means ± SD (n=6). Pairs of values within a given cell type which are significantly different 
(P<0.05) are shown (*). Pairs of values within a given dietary treatment which are significantly different (P<0.05) 
are shown (†). pp: protein. h: hour. FO: Fish oil. EO: Echium oil. Elo/des: the sum of elongation and desaturation 
activity. 
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